MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31.

Income Overview

Net Income
-$11,837K
EPS
-$0.26
Unit: Thousand (K) dollars

Income Statement
2025-12-31
2025-09-30
2025-06-30
2025-03-31
Royalties and license fees
--0 -
Total revenues
0 0 --
Research and development
5,834 3,370 3,695 5,980
General and administrative
7,543 6,433 13,481 4,208
Total operating expenses
13,377 9,803 17,176 10,188
Loss from operations
-13,377 -9,803 -17,176 -10,188
Foreign currency transaction loss (gain)
131 -89 119 11
Interest income, net
1,390 1,011 1,036 823
Other income (expense), net
19 -84 -123* -
Loss on extinguishment of liabilities
0 --2* -
Unrealized loss on investment
--0* -
Total other income, net
1,540 838 1,029 834
Net loss
-11,837 -8,965 -16,147 -9,354
Unrealized foreign currency translation gain (loss)
-89 --
Total other comprehensive income (loss)
-89 --
Total comprehensive loss
--8,876 --
Net loss attributable to common shareholders
-11,837 ---
Basic EPS
-0.26 -0.22 -0.446 -0.24
Diluted EPS
-0.26 -0.22 -0.446 -0.24
Basic Average Shares
45,970,516 41,521,280 36,209,271* 38,599,453
Diluted Average Shares
45,970,516 41,521,280 36,209,271* 38,599,453
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$11,837K Interest income, net$1,390K (68.89%↑ Y/Y)Foreign currencytransaction loss (gain)$131K (144.56%↑ Y/Y)Other income(expense), net$19K (147.50%↑ Y/Y)Net loss-$11,837K (-60.89%↓ Y/Y)Total other income,net$1,540K (22.91%↑ Y/Y)Loss from operations-$13,377K (-55.37%↓ Y/Y)Total operatingexpenses$13,377K (55.37%↑ Y/Y)General andadministrative$7,543K (113.20%↑ Y/Y)Research and development$5,834K (15.02%↑ Y/Y)

Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Inc. (BNTC)